Approaches for Gastro Retentive Drug Delivery System: A Review
Chinmaya Keshari Sahoo, Subhashree Mishra, Amiyakanta Mishra
Abstract:
To increase the therapeutic efficacy of medications with a limited absorption window, unstable at alkaline pH, soluble in acidic environments, and localized stomach activity, a variety of gastroretentive drug delivery systems (GRDDS) have been employed. In this overview, we go over the physiological state of the stomach, and different GRDDS techniques.
Keywords: GRDDS, Therapeutic Efficacy, Acidic Environments.
References:
[1] Streubel A, Siepmann J, Bodmeier R. Gastroretentive drug delivery system. Expert Opin Drug Deliv 2006; 3(2): 217-33.
[2] Iannucelli V, Coppi G, Bernabei MT, Camerorni R. Air compertment multipleunit system for rolonged gastric residence. Part-I. Formulation study. Int J Pharm 1998; 174: 47-54.
[3] Garg R, Gupta GD. Progress in controlled gastroretentive delivery systems. Trop. J Pharm Res 2008; 7(3): 1055-66.
[4] Rouge, N.; Buri, P.; Doelker, E. Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int. J. Pharm. 1996; 136: 117–139.
[5] Streubel A, Siepmann J, Bodmeier R. Multiple unit Gastroretentive drug delivery: a new preparation method for low density microparticles. J Microencapsul 2003; 20:329-47.
[6] Goole J, Vanderbist F, Aruighi K. Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms. Int J Pharm 2007; 334: 35-41.
[7] Shrma S, Pawar A. Low density multiparticulate system for pulsatile release of meloxicam. Int J Pharm 2006; 313:150-58.
[8] Lopes, C.M.; Bettencourt, C.; Rossi, A.; Buttini, F.; Barata, P. Overview on gastroretentive drug delivery systems for improving drug bioavailability. Int. J. Pharm. 2016, 510, 144–158.
[9] Klausner EA, Lavy E, Friedman M, Hoffman A. Expandable gastroretentive dosageforms. J Control Release 2003; 90: 143-62.
[10] Deshpande AA, Shah N, Rhodes CT, Malik W. Development of a novel controlledrelease system for gastric retention. Pharm Res 1997; 14: 815-19.
[11] Park K. Enzyme-digestible swelling as platforms for longterm oral drug delivery: synthesis and characterization. Biomaterials 1988; 9: 435.
[12] Fujimori J, Machida Y, Nagai T. Preparation of a magnetically-responsive tablet and configuration of its gastric residence in beagle dogs. STP Pharma Sci 1994; 4:425- 30.
[13] Wilson CG, Washington N. The stomach: its role in oral drug delivery. In: Rubinstein, MH, editors. Physiological Pharmaceutical: Biological barriers to drug absorption.Chichester, U.K.: Ellis Horwood. 1989; 47-70.
[14] Streubel A, Siepmann J, Bodmeier R. Drug delivery to the upper small intestine window using Gastroretentive technologies. Curr Opin Pharmacol 2006; 6: 501-8.
[15] Awasthi, R.; Kulkarni, G.T. Decades of research in drug targeting to the upper gastrointestinal tract using gastroretention technologies: Where do we stand? Durg Deliv. 2016; 23: 378–394.
[16] Prinderre, P.; Sauzet, C.; Fuxen, C. Advances in gastro retentive drug-delivery systems. Expert Opin. Drug Deliv. 2011, 8, 1189– 1203.
[17] Arrora S, Ali J, Khar RK, Baboota S. Floatng drug delivery systems: A review. AAPS Pharm Sci Tech 2005; 6(3):372-90.
[18] El-Kamel AH, Sokar MS, Al Gamal SS, Naggar VF. Preparation and evaluation of ketoprofen floating oral delivery system. Int J Parm 2001; 220: 13-21.
[19] Garg S, Sharma S. Gastroretentive drug delivery systems. Business Briefing: Pharmatech 2003: 160-66.
[20] Khosla R, Feely LC, Davis SS. Gastrointestinal transit of nondisintegrating tablets in fed subjects. Int J Pharm1989; 53: 107-17.
[21] Mojaverian P, Vlasses PH, Kellner PE, RocciJr ML. Effects of gender, posture and age on gastric residence time of an indigestible solid: Pharmaceutical considerations. Pharm Res 1988; 10: 639- 44.
[22] Vyas SP, Khar RK. Gastroretentive systems. In: Controlled drug Delivery. Vallabh Prakashan, Delhi, India. 2006;197-217.
[23] Tripathi J, Thapa P, Maharjan R, Jeong SH. Current State and Future Perspectives on Gastroretentive Drug Delivery Systems. Pharmaceutics 2019; 11: 193
[24] Reddy LH, Murthy RS. Floating dosage system in drug delivery. Crit Rev Ther Drug Carrier Syst 2002; 19(6):553-85. [25] Sing BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Rel 2000; 63: 235-59.
[26] Sahoo CK, Dasari P, Dandamundi S, Karnati N, Kokkula S, Patro MK. A Review on Floating Drug Delivery System. International Journal of Pharmaceutical Research and Development. 2013; 4(11):1- 16.